White House Executive Order Accelerates Psychedelic Drug Treatments for Serious Mental Illness
β’ President issues executive order on April 18, 2026, to speed medical treatments for serious mental illness using psychedelic drugs including ibogaine compounds. β’ Order highlights clinical studies showing potential for patients with persistent conditions unresponsive to standard therapies. β’ Directs federal agencies to prioritize research, approvals, and access to innovative mental health interventions nationwide.
Read original Β· whitehouse.gov
White House
